Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin

Journal of Clinical Microbiology

Volumn 38, Issue 8, 2000, Pages 2819-2823

  Von Eiff, C ^a   Reinert, R R ^a   Kresken, M ^a   Brauers, J ^a   Hafner, D ^a   Peters, G ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; QUINUPRISTIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

EID: 0033889695     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.8.2819-2823.2000     Document Type: Article

References (22)

1. Gram-positive resistance: Challenge for the development of new antibiotics
2. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin
3. Epidemiology and prevention of nosocomial infections
4. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
5. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
6. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: The role of streptogramins and other newer compounds
7. Pravalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa
8. Drug resistance among clinical isolates of frequently encountered bacterial species in Central Europe during 1975-1995
9. Staphylococcus aureus infections
10. A novel antimicrobial agent joins the battle against resistant bacteria
11. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
12. Problems with antimicrobial resistance in gram-positive cocci
13. Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: Two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomyin
14. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
15. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
16. European survey of glycopeptide susceptibility in Staphylococcus spp.
17. Emergence of vancomycin resistance in Staphylococcus aureus
18. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: Impact of intravascular devices and methicillin resistance
19. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
20. Antibiotic resistance in staphylococci in Europe
21. Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals